anmelden
SLI
2.099,95
PKT
-6,32
PKT
-0,30
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.07.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 21.07.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 21.07.22 | UBS Neutral | Goldman Sachs Group Inc. | |
| 21.07.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.07.22 | Givaudan Underperform | Bernstein Research | |
| 21.07.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.07.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 21.07.22 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 20.07.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 20.07.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 20.07.22 | Novartis Neutral | Credit Suisse Group | |
| 20.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.07.22 | Roche Hold | Deutsche Bank AG | |
| 20.07.22 | Novartis Sell | Deutsche Bank AG | |
| 20.07.22 | Swiss Re Equal Weight | Barclays Capital | |
| 19.07.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.07.22 | Richemont Buy | Deutsche Bank AG | |
| 19.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 19.07.22 | Novartis Neutral | UBS AG | |
| 19.07.22 | Novartis Buy | Jefferies & Company Inc. | |
| 19.07.22 | Nestlé Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.07.22 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.07.22 | UBS Underweight | Barclays Capital | |
| 19.07.22 | UBS Underweight | Barclays Capital | |
| 18.07.22 | Richemont Overweight | JP Morgan Chase & Co. | |
| 18.07.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 18.07.22 | Richemont Buy | Deutsche Bank AG | |
| 18.07.22 | Richemont Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.07.22 | Novartis Underweight | Barclays Capital | |
| 18.07.22 | Roche Overweight | Barclays Capital | |
| 18.07.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 18.07.22 | Nestlé Buy | Goldman Sachs Group Inc. | |
| 18.07.22 | Richemont Buy | UBS AG | |
| 15.07.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 15.07.22 | Nestlé Market-Perform | Bernstein Research | |
| 15.07.22 | Richemont Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.07.22 | Richemont Buy | Jefferies & Company Inc. | |
| 15.07.22 | Richemont Outperform | Bernstein Research | |
| 15.07.22 | Richemont Outperform | RBC Capital Markets |